Yoon P. Lim

Singapore, 119077, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

WBP2 Attenuates Metformin Response in HER2-Positive Breast Cancer Cells by Repressing AMPK Activation and Inducing a Lower AMP:ATP Ratio State Through Enhanced ATP Production.

WBP2 Attenuates Metformin Response in HER2-Positive Breast Cancer Cells by Repressing AMPK Activation and Inducing a Lower AMP:ATP Ratio State Through Enhanced ATP Production.

Journal: Cells

Published: January 19, 2026

WFIKKN2 is secreted and elevated in blood plasma of HER2-positive breast cancer patients - implications in cancer surveillance and recurrence monitoring.

WFIKKN2 is secreted and elevated in blood plasma of HER2-positive breast cancer patients - implications in cancer surveillance and recurrence monitoring.

Journal: Biomarker research

Published: July 01, 2025

Overexpression of DDR1 contributes to gastric cancer progression by inhibiting the Hippo pathway.

Overexpression of DDR1 contributes to gastric cancer progression by inhibiting the Hippo pathway.

Journal: Journal of biomedical research

Published: June 02, 2025

WBP2 and its network of transcription coregulators in an expanding repertoire of human cancers.

WBP2 and its network of transcription coregulators in an expanding repertoire of human cancers.

Journal: International journal of cancer

Published: April 13, 2025

Genomic, transcriptomic, and metabolomic analysis of Oldenlandia corymbosa reveals the biosynthesis and mode of action of anti-cancer metabolites.

Genomic, transcriptomic, and metabolomic analysis of Oldenlandia corymbosa reveals the biosynthesis and mode of action of anti-cancer metabolites.

Journal: Journal of integrative plant biology

Published: July 13, 2022

Reciprocal Regulation of Hippo and WBP2 Signalling-Implications in Cancer Therapy.

Reciprocal Regulation of Hippo and WBP2 Signalling-Implications in Cancer Therapy.

Journal: Cells

Published: September 13, 2021

WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-κB activation.

WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-κB activation.

Journal: Molecular oncology

Published: March 10, 2021

WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex.

WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex.

Journal: Life science alliance

Published: January 27, 2021

Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer.

Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer.

Journal: Cell death & disease

Published: March 30, 2020

The emerging roles of WBP2 oncogene in human cancers.

The emerging roles of WBP2 oncogene in human cancers.

Journal: Oncogene

Published: March 04, 2020

Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study.

Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 03, 2018

The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway.

The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway.

Journal: The Journal of biological chemistry

Published: September 10, 2018

Showing 1-12 of 32

Last Updated: 09/26/2026